Professor Marina Kennerson is a leading academic at the University of Sydney , affiliated with the Faculty of Medicine and Health and the School of Medical Sciences . She serves as Director of the Northcott Neuroscience Laboratory (ANZAC Research Institute), Principal Hospital Scientist at Concord Hospital's Molecular Medicine Laboratory, and Deputy Director (Research) for the Sydney Local Health District Institute of Precision Medicine and Bioinformatics. Her work focuses on Neurogenetics , particularly identifying causative genes for Inherited Peripheral Neuropathies (IPN), with over 25 years of experience in the field. Research Interests Gene discovery for IPN using genetic linkage and next-generation sequencing Functional genomics via iPSC-derived motor neurons and C. elegans models Transition of genomic technologies to clinical neurogenetic testing Leadership in global consortia like the Peripheral Nerve Society and Asian Oceanic Inherited Neuropathy Consortium Scientific Contributions Her research program integrates multiomics approaches with AI tools to analyze genomic data. She has identified 10 causative IPN genes and two structural variation mutations (DHMN1 and CMTX3), advancing pre-clinical modeling and therapeutic development. Her lab's work has established Concord Hospital as a reference center for IPN testing in Australia. Collaborations International partnerships include collaborations with: University of Malaya (Malaysia) – Dr. Azlina Ahmad-Annuar and Dr. Nortina Shahrizaila University of Miami (USA) – Professor Stephan Zuchner





.jpeg)






